This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Oct 1;76(10):1007-1008.

doi: 10.1001/jamapsychiatry.2019.1656.

Clozapine and Evidence-Based Psychopharmacology for Schizophrenia

T Scott Stroup¹

Affiliations

PMID: 31365031
DOI: 10.1001/jamapsychiatry.2019.1656

Editorial

Clozapine and Evidence-Based Psychopharmacology for Schizophrenia

T Scott Stroup. JAMA Psychiatry. 2019.

. 2019 Oct 1;76(10):1007-1008.

doi: 10.1001/jamapsychiatry.2019.1656.

Author

T Scott Stroup¹

Affiliation

¹ Department of Psychiatry, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York.

PMID: 31365031
DOI: 10.1001/jamapsychiatry.2019.1656

No abstract available

PubMed Disclaimer

Comment on

Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
Masuda T, Misawa F, Takase M, Kane JM, Correll CU. Masuda T, et al. JAMA Psychiatry. 2019 Oct 1;76(10):1052-1062. doi: 10.1001/jamapsychiatry.2019.1702. JAMA Psychiatry. 2019. PMID: 31365048 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information